Medicus Pharma Ltd (NASDAQ:MDCX) Short Interest Update

Medicus Pharma Ltd (NASDAQ:MDCX) was the recipient of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 3,559,666 shares, a growth of 290.7% from the February 26th total of 911,128 shares. Approximately 15.7% of the shares of the company are short sold. Based on an average trading volume of 20,131,918 shares, the days-to-cover ratio is presently 0.2 days. Based on an average trading volume of 20,131,918 shares, the days-to-cover ratio is presently 0.2 days. Approximately 15.7% of the shares of the company are short sold.

Analyst Ratings Changes

Several research analysts recently issued reports on MDCX shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Medicus Pharma in a report on Monday, December 29th. D. Boral Capital reaffirmed a “buy” rating and set a $27.00 price target on shares of Medicus Pharma in a research report on Thursday, March 19th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $23.50.

Hedge Funds Weigh In On Medicus Pharma

Large investors have recently made changes to their positions in the company. Private Advisor Group LLC lifted its stake in Medicus Pharma by 3.8% in the 3rd quarter. Private Advisor Group LLC now owns 151,500 shares of the company’s stock valued at $351,000 after buying an additional 5,500 shares in the last quarter. Osaic Holdings Inc. boosted its holdings in Medicus Pharma by 180.0% in the 2nd quarter. Osaic Holdings Inc. now owns 14,000 shares of the company’s stock worth $42,000 after buying an additional 9,000 shares during the last quarter. Jane Street Group LLC purchased a new stake in Medicus Pharma during the 2nd quarter worth approximately $41,000. Commonwealth Equity Services LLC increased its stake in Medicus Pharma by 161.8% during the 4th quarter. Commonwealth Equity Services LLC now owns 28,493 shares of the company’s stock worth $44,000 after buying an additional 17,611 shares in the last quarter. Finally, May Hill Capital LLC raised its holdings in shares of Medicus Pharma by 100.0% during the fourth quarter. May Hill Capital LLC now owns 35,622 shares of the company’s stock valued at $55,000 after acquiring an additional 17,811 shares during the last quarter.

Medicus Pharma Trading Down 2.2%

Shares of NASDAQ:MDCX opened at $0.49 on Wednesday. Medicus Pharma has a 12-month low of $0.37 and a 12-month high of $8.94. The business has a 50 day moving average of $1.03 and a two-hundred day moving average of $1.74. The company has a market capitalization of $12.49 million, a PE ratio of -0.23 and a beta of -1.58.

About Medicus Pharma

Medicus Pharma, Inc, traded on the Nasdaq under the ticker MDCX, is a specialty pharmaceutical company focused on the development, acquisition and commercialization of prescription therapies. The company’s core business centers on oncology supportive care and critical care products, with its lead offering being Levoleucovorin injection, an FDA-approved agent designed to reduce toxicity and enhance efficacy of certain chemotherapeutic regimens in colorectal cancer.

Headquartered in the United States, Medicus Pharma has built its portfolio through strategic licensing and acquisition of sterile injectable and oral therapies.